Glycinebetaine

Glycinebetaine

SCHEMBL16817822

COc1cc2oc(-c3cc[n+](CCCCCC(=O)O)cc3)nc2cc1S(=O)(=O)[O-].C[N+](C)(C)CC(=O)[O-]

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

BHMTBHMT2

The experimentally established mechanism targets of Glycinebetaine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 5/20 0.35
HDAC4 P56524 5/20 0.35
HDAC1 Q13547 5/20 0.35
HDAC7 Q8WUI4 5/20 0.35
HDAC2 Q92769 5/20 0.35
HDAC10 Q969S8 5/20 0.35
HDAC11 Q96DB2 5/20 0.35
HDAC8 Q9BY41 5/20 0.35
HDAC6 Q9UBN7 5/20 0.35
HDAC9 Q9UKV0 5/20 0.35
HDAC5 Q9UQL6 5/20 0.35
MAPK1 P28482 1/20 0.35
PTPN2 P17706 5/20 0.34
PTPN1 P18031 5/20 0.34
PTPN5 P54829 5/20 0.34
KDR P35968 2/20 0.34
HSPD1 P10809 3/20 0.33
HSPE1 P61604 3/20 0.33
PDE10A Q9Y233 1/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycinebetaine SCHEMBL16817804 0.93 CETP (0.33) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL16815320 0.93 PTPN2 (0.38) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL16844909 0.85 HDAC3 (0.40) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL16815235 0.84 FABP3 (0.36) SMN1; SMN2TP53
Glycinebetaine SCHEMBL16817781 0.83 S1PR1 (0.35) HDAC3HDAC4HDAC1HDAC7HDAC2
Glycinebetaine SCHEMBL16817774 0.80 TLR7 (0.38) KDM4EALDH1A1SMN1; SMN2MAPT
SCHEMBL20057440 0.77 HDAC3 (0.39) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL16848752 0.77 FABP3 (0.37) HDAC3HDAC4HDAC1HDAC7HDAC2
Glycinebetaine SCHEMBL16817742 0.76 HDAC3 (0.43) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL16815239 0.74 HDAC6 (0.48) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9453010-B2 Marker dyes for UV and short wave excitation with high stokes shift based on benzoxazoles DYOMICS GMBH (DE) 2016-09-27 US disclosed
US-20150175591-A1 MARKER DYES FOR UV AND SHORT WAVE EXCITATION WITH HIGH STOKES SHIFT BASED ON BENZOXAZOLES DYOMICS GMBH (DE) 2015-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150175591-A1 MARKER DYES FOR UV AND SHORT WAVE EXCITATION WITH HIGH STOKES SHIFT BASED ON BENZOXAZOLES NR2E3, H1-10, NR0B1 HDAC3 539/4885HDAC4 561/4885HDAC1 804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.